Clinical Experience with Long-term Lamivudine Therapy to Determine the Adequate Duration of Treatment in Children and Adolescents with HBeAg-Negative Chronic Hepatitis B

2009 ◽  
Vol 12 (1) ◽  
pp. 23 ◽  
Author(s):  
Jung Mi Kim ◽  
Suk Jin Hong ◽  
Byung Ho Choi ◽  
Mi Ae Chu ◽  
Seung Man Cho ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Children And Adolescents ◽  
Chronic Hepatitis B ◽  
Clinical Experience ◽  
Duration Of Treatment ◽  
Lamivudine Therapy ◽  
Negative Chronic Hepatitis

Efficacy of long term lamivudine therapy in HBeAg negative chronic hepatitis B

2000 ◽  
Vol 118 (4) ◽  
pp. A1004
Author(s):  
Evangelini Dimou ◽  
George V. Papatheodoridis ◽  
Andreas Laras ◽  
Stephanos J. Hadziyannis
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Lamivudine Therapy ◽  
Negative Chronic Hepatitis

Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients

2011 ◽  
Vol 31 (10) ◽  
pp. 1525-1532 ◽  
Author(s):  
Spilios Manolakopoulos ◽  
Athanasia Striki ◽  
Melanie Deutsch ◽  
Maria Mela ◽  
Ioannis Ketikoglou ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Creatinine Clearance ◽  
Chronic Hepatitis B ◽  
Lamivudine Therapy ◽  
Negative Chronic Hepatitis

Efficacy of long term lamivudine therapy in HBeAg negative chronic hepatitis B

2000 ◽  
Vol 32 ◽  
pp. 98 ◽  
Author(s):  
E. Dimou ◽  
G.V. Papatheodoridis ◽  
A. Laras ◽  
S.J. Hadziyannis
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Lamivudine Therapy ◽  
Negative Chronic Hepatitis

Long-Term Results of Interferon Alpha Monotherapy in Patients with HBeAg-Negative Chronic Hepatitis B

2007 ◽  
Vol 52 (3) ◽  
pp. 727-731 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Ahmet Danalioglu ◽  
Kadir Demir ◽  
Cetin Karaca ◽  
Filiz Akyuz ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Long Term Results ◽  
Negative Chronic Hepatitis

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

2018 ◽  
Vol 23 (8) ◽  
pp. 711
Author(s):  
George V Papatheodoridis ◽  
Eirini I Rigopoulou ◽  
Margarita Papatheodoridi ◽  
Kalliopi Zachou ◽  
Vassilios Xourafas ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Term Therapy ◽  
Hbsag Loss ◽  
Long Term Therapy ◽  
Negative Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document